Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 24259347)

1.

Obesity consults--comprehensive obesity management in 2013: understanding the shifting paradigm.

Kushner RF, Apovian CM, Fujioka K.

Obesity (Silver Spring). 2013 Nov;21 Suppl 2:S3-13; quiz S14-5. doi: 10.1002/oby.20627. Review.

PMID:
24259347
2.

Formulary management of 2 new agents: lorcaserin and phentermine/topiramate for weight loss.

Kelly EM, Tungol AA, Wesolowicz LA.

J Manag Care Pharm. 2013 Oct;19(8):642-54. Review.

3.

A review of the metabolic effects of controlled-release Phentermine/Topiramate.

Kiortsis DN.

Hormones (Athens). 2013 Oct-Dec;12(4):507-16. Review.

4.

New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia).

Shyh G, Cheng-Lai A.

Cardiol Rev. 2014 Jan-Feb;22(1):43-50. doi: 10.1097/CRD.0000000000000001. Review.

PMID:
24304809
5.

Phentermine and topiramate for the management of obesity: a review.

Cosentino G, Conrad AO, Uwaifo GI.

Drug Des Devel Ther. 2011 Apr 5;7:267-78. doi: 10.2147/DDDT.S31443. Print 2013. Review.

6.

Phentermine and topiramate extended-release for the obesity: new kids on the block.

Katsi V, Marketou M, Kallistratos MS, Tousoulis D, Makris T, Manolis AJ, Vardas P, Kallikazaros I.

Recent Pat Cardiovasc Drug Discov. 2013 Apr;8(1):35-41. Review.

PMID:
23565717
7.

New obesity agents: lorcaserin and phentermine/topiramate.

Fleming JW, McClendon KS, Riche DM.

Ann Pharmacother. 2013 Jul-Aug;47(7-8):1007-16. doi: 10.1345/aph.1R779. Epub 2013 Jun 25. Review.

PMID:
23800750
8.

Overview of new antiobesity drugs.

Hainer V.

Expert Opin Pharmacother. 2014 Oct;15(14):1975-8. doi: 10.1517/14656566.2014.946904. Epub 2014 Aug 6. Review.

PMID:
25100293
9.

Combination phentermine/topiramate for obesity treatment in primary care: a review.

Xiong GL, Gadde KM.

Postgrad Med. 2014 Mar;126(2):110-6. doi: 10.3810/pgm.2014.03.2746. Review.

PMID:
24685974
10.

Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.

Bays H.

Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1777-801. doi: 10.1586/erc.10.125. Epub 2010 Aug 16. Review.

PMID:
20707765
11.

Fixed-dose combination of phentermine-topiramate for the treatment of obesity.

Halpern B, Faria AM, Halpern A.

Expert Rev Clin Pharmacol. 2013 May;6(3):235-41. doi: 10.1586/ecp.13.13. Review.

PMID:
23656337
12.

New pharmacological treatments for the management of obesity.

Hurt RT, Edakkanambeth Varayil J, Ebbert JO.

Curr Gastroenterol Rep. 2014;16(6):394. doi: 10.1007/s11894-014-0394-0. Review.

PMID:
24828101
13.

Drug treatment of obesity in the cardiovascular patient.

Charakida M, Tousoulis D, Finer N.

Curr Opin Cardiol. 2013 Sep;28(5):584-91. doi: 10.1097/HCO.0b013e3283642a4c. Review.

PMID:
23928924
14.

New medications for obesity management: changing the landscape of obesity treatment.

Boulghassoul-Pietrzykowska N, Franceschelli J, Still C.

Curr Opin Endocrinol Diabetes Obes. 2013 Oct;20(5):407-11. doi: 10.1097/01.med.0000433059.78485.fa. Review.

PMID:
23974768
15.

The new weight-loss drugs, lorcaserin and phentermine-topiramate: slim pickings?

Woloshin S, Schwartz LM.

JAMA Intern Med. 2014 Apr;174(4):615-9. doi: 10.1001/jamainternmed.2013.14629.

PMID:
24515599
16.
17.

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.

Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, Schwiers M, Day WW, Bowden CH.

Am J Clin Nutr. 2012 Feb;95(2):297-308. doi: 10.3945/ajcn.111.024927. Epub 2011 Dec 7.

18.

Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.

Bays HE, Gadde KM.

Drugs Today (Barc). 2011 Dec;47(12):903-14. doi: 10.1358/dot.2011.47.12.1718738. Review. Erratum in: Drugs Today (Barc). 2012 Jan;48(1):95.

PMID:
22348915
19.

Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery?

Miras AD, le Roux CW.

Int J Obes (Lond). 2014 Mar;38(3):325-33. doi: 10.1038/ijo.2013.205. Epub 2013 Nov 11. Review.

20.

Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management.

Garvey WT.

Expert Opin Drug Saf. 2013 Sep;12(5):741-56. doi: 10.1517/14740338.2013.806481. Epub 2013 Jun 6. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk